Shareholders in 2seventy bio, Inc. ( NASDAQ:TSVT ) had a terrible week, as shares crashed 22% to US$3.92 in the ...

Cash Runway: Expected to extend beyond 2027. 2seventy bio Inc (NASDAQ:TSVT) successfully completed the sale of its oncology and autoimmune R&D pipeline to Regeneron, streamlining operations. The ...

TD Cowen analyst Yaron Werber maintained a Hold rating on 2seventy bio (TSVT – Research Report) today. The company’s shares closed ...

Inc. (TSVT) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $1 per share a year ago. These figures are adjusted for ...

Total revenue for Q3 was $13.5 million, missing the $16.2 million analyst estimate. Operating expenses dropped by 24%, ...

The latest announcement is out from 2seventy bio ( (TSVT) ). 2seventy bio reported impressive third-quarter results with a 42% increase in ...

Discovery Channel show explores origin stories of Nintendo, Atari, 'Call of Duty,' 'Minecraft,' 'Monopoly' and more.

Shares of 2seventy bio were trading at $4.73 as of November 07. Over the last 52-week period, shares are up 107.46%. Given that these returns are generally positive, long-term shareholders should be ...

Detroit Lions head coach Dan Campbell says he is not surprised team played well in the elements, is built to win NFL games. Philadelphia Eagles wide receiver makes an unreal one-handed, toe-dragging ...

NEW YORK, Nov. 2, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of 2seventy bio, Inc. ("2seventy bio" or the "Company") (NASDAQ: TSVT). Such investors are ...

BMY’s cell therapy Abecma, marketed with 2seventy bio (TSVT), generated $124M with ~33% YoY growth. On a non-GAAP basis, Bristol-Myers’ (NYSE:BMY) gross margin dropped to 77.3% from 76.0% in ...